Uygur M M, di Filippo L, Frara S, Menotti S, Giustina A
Institute of Endocrine and Metabolic Sciences, Università Vita-Salute San Raffaele, IRCCS Ospedale San Raffaele, Milan, Italy.
Department of Endocrinology and Metabolism Disease, School of Medicine, Recep Tayyip Erdoğan University, Rize, Turkey.
Endocrine. 2025 May 28. doi: 10.1007/s12020-025-04260-5.
Adrenal diseases are associated with an increased risk of osteopenia/osteoporosis and fragility fractures. Although dual-energy X-ray absorptiometry remains the gold standard for assessing bone mineral density, its limitations in accurately predicting vertebral fractures underscore the need for complementary diagnostic tools, particularly in the context of adrenal disorders. Vertebral fractures, often asymptomatic, may go undetected without targeted assessments such as morphometric evaluation. Incorporating advanced diagnostic tools, such as the trabecular bone score, into the evaluation of adrenal disorder-related skeletal fragility may enhance the identification of high-risk patients and support tailored therapeutic strategies. This review explores skeletal fragility from pathophysiological, clinical, and diagnostic perspectives and provides guidance to physicians for the management of adrenal disorders to improve bone health outcomes.
肾上腺疾病与骨质减少/骨质疏松症及脆性骨折风险增加相关。尽管双能X线吸收法仍是评估骨密度的金标准,但其在准确预测椎体骨折方面的局限性凸显了对补充诊断工具的需求,尤其是在肾上腺疾病的背景下。椎体骨折通常无症状,若没有诸如形态计量学评估等针对性评估可能无法被发现。将先进的诊断工具,如小梁骨评分,纳入肾上腺疾病相关骨骼脆性的评估中,可能会加强对高危患者的识别,并支持量身定制的治疗策略。本综述从病理生理、临床和诊断角度探讨骨骼脆性,并为医生管理肾上腺疾病以改善骨骼健康结果提供指导。